Capricor Therapeutics reported $53.93M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Bluebird Bio BLUE:US USD 520.1M 53.49M
Capricor Therapeutics CAPR:US USD 53.93M 4.14M
Cytokinetics CYTK:US USD 1.08B 304.24M
Cytori Therapeutics CYTX:US USD 23.1M 1.83M
Newlink Genetics NLNK:US USD 79.21M 6.24M
Prothena PRTA:US USD 554.44M 4.85M
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Vascular Biogenics VBLT:US USD 35.53M 9.79M
Vital Therapies VTL:US USD 121.08M 17.57M